Agnico Eagle Mines Limited (AEM)vsBristol-Myers Squibb Company (BMY)
AEM
Agnico Eagle Mines Limited
$193.21
+2.90%
BASIC MATERIALS · Cap: $93.89B
BMY
Bristol-Myers Squibb Company
$56.16
-0.16%
HEALTHCARE · Cap: $114.68B
Smart Verdict
WallStSmart Research — data-driven comparison
Bristol-Myers Squibb Company generates 258% more annual revenue ($48.48B vs $13.54B). AEM leads profitability with a 39.5% profit margin vs 15.0%. AEM appears more attractively valued with a PEG of 28.15. AEM earns a higher WallStSmart Score of 75/100 (B+).
AEM
Strong Buy75
out of 100
Grade: B+
BMY
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-12.6%
Fair Value
$192.97
Current Price
$193.21
$0.24 premium
Margin of Safety
+32.0%
Fair Value
$88.08
Current Price
$56.16
$31.92 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 40 of every $100 in revenue as profit
Strong operational efficiency at 62.8%
Revenue surging 66.1% year-over-year
Earnings expanding 108.6% YoY
Conservative balance sheet, low leverage
Large-cap with strong market position
Every $100 of equity generates 39 in profit
Strong operational efficiency at 33.0%
Large-cap with strong market position
Attractively priced relative to earnings
Areas to Watch
Expensive relative to growth rate
2.6% revenue growth
Expensive relative to growth rate
Distress zone — elevated risk
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : AEM
The strongest argument for AEM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 39.5% and operating margin at 62.8%. Revenue growth of 66.1% demonstrates continued momentum.
Bull Case : BMY
The strongest argument for BMY centers on Return on Equity, Operating Margin, Market Cap.
Bear Case : AEM
The primary concerns for AEM are PEG Ratio.
Bear Case : BMY
The primary concerns for BMY are Revenue Growth, PEG Ratio, Altman Z-Score. Debt-to-equity of 2.55 is elevated, increasing financial risk.
Key Dynamics to Monitor
AEM profiles as a growth stock while BMY is a value play — different risk/reward profiles.
AEM carries more volatility with a beta of 0.57 — expect wider price swings.
AEM is growing revenue faster at 66.1% — sustainability is the question.
BMY generates stronger free cash flow (757M), providing more financial flexibility.
Bottom Line
AEM scores higher overall (75/100 vs 60/100), backed by strong 39.5% margins and 66.1% revenue growth. BMY offers better value entry with a 32.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agnico Eagle Mines Limited
BASIC MATERIALS · GOLD · USA
Agnico Eagle Mines Limited is engaged in the exploration, development and production of mineral properties in Canada, Sweden and Finland. The company is headquartered in Toronto, Canada.
Visit Website →Bristol-Myers Squibb Company
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
Visit Website →Compare with Other GOLD Stocks
Want to dig deeper into these stocks?